News PharmaSGP Holding SE

Equities

PSG

DE000A2P4LJ5

Real-time Estimate Tradegate Other stock markets 03:30:07 2024-07-08 am EDT			5-day change	1st Jan Change
21.4 ^EUR	0.00%		-7.76%	-4.89%

May. 28	PharmaSGP Holding SE Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 29	PharmaSGP Holding SE Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

PharmaSGP : Information according to Table 8 of the Implementing Regulation (EU) 2018/1212 (German Language)	Jun. 27	PU
PharmaSGP Holding SE: Annual General Meeting approves full distribution of the Group’s profit for 2023 following a successful business performance	Jun. 27	EQ
PharmaSGP Holding SE strengthens the Management Board to further accelerate growth	Jun. 21	EQ
PharmaSGP : Interim Statement Q1 2024	May. 28	PU
PharmaSGP Holding SE Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 27	CI
PharmaSGP : Sample Form for Revocation of Power of Attorney	May. 16	PU
PharmaSGP continues dynamic business development with significant revenues growth in Q1 2024	May. 14	EQ
PharmaSGP Holding SE Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 29	CI
AFR: PharmaSGP Holding SE: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]	Apr. 22	EQ
PharmaSGP Holding SE proposes an increased dividend of EUR 1.36 per share for 2023	Apr. 18	EQ
PharmaSGP Holding SE Proposes Dividend for the Financial Year 2023	Apr. 18	CI
PharmaSGP Holding SE Announces Changes to Dividend Policy	Apr. 18	CI
PharmaSGP exceeds the € 100 million revenues mark in 2023 and plans further profitable growth in 2024	Apr. 16	EQ
PharmaSGP Holding SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	Jan. 04	EQ
PharmaSGP Holding SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	Dec. 11	EQ
PharmaSGP Holding SE Reports Earnings Results for the Nine Months Ended September 30, 2023	Nov. 29	CI
PharmaSGP continues the profitable growth course of the previous quarters in the third quarter of 2023	Nov. 14	EQ
PharmaSGP Holding SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	23-10-12	EQ
PharmaSGP Holding SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	23-10-12	EQ
Tranche Update on PharmaSGP Holding SE's Equity Buyback Plan announced on January 9, 2023.	23-09-27	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News PharmaSGP Holding SE

Equities

PSG

DE000A2P4LJ5

Summary

Filters